OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $73,195 | +88.2% | 13,889 | +0.4% | 0.00% | – |
| Q4 2022 | $38,888 | -39.2% | 13,839 | -10.1% | 0.00% | – |
| Q3 2022 | $64,000 | -85.0% | 15,394 | -41.0% | 0.00% | -100.0% |
| Q1 2021 | $428,000 | -12.5% | 26,083 | +10.5% | 0.00% | 0.0% |
| Q4 2020 | $489,000 | +244.4% | 23,600 | +26.9% | 0.00% | – |
| Q3 2020 | $142,000 | +91.9% | 18,600 | -0.6% | 0.00% | – |
| Q4 2019 | $74,000 | +48.0% | 18,713 | +14.1% | 0.00% | – |
| Q3 2019 | $50,000 | -3.8% | 16,400 | +37.8% | 0.00% | – |
| Q2 2019 | $52,000 | -42.2% | 11,900 | -18.5% | 0.00% | – |
| Q3 2017 | $90,000 | +25.0% | 14,600 | +87.2% | 0.00% | – |
| Q2 2017 | $72,000 | 0.0% | 7,800 | 0.0% | 0.00% | – |
| Q1 2017 | $72,000 | +188.0% | 7,800 | +160.0% | 0.00% | – |
| Q4 2016 | $25,000 | +257.1% | 3,000 | +200.0% | 0.00% | – |
| Q3 2016 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |